Trial NCT04412538
Publication Pu J, Vaccine, 2021
Primary outcome on the report: Total rate of adverse reactions from 0 to 28 days postimmunization

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.